Characterising the microbial and antimicrobial resistance signatures of hospital-acquired pneumonia using nanopore metagenomic sequencing

  24 August 2025

Hospital-acquired pneumonia (HAP) is a serious infection, but its microbial causes are not fully understood. In a UK study of 250 HAP patients, researchers used advanced nanopore sequencing to analyse respiratory microbiomes, confirming results with PCR and culture tests. Sequencing detected key pathogens and even identified likely microbes in nearly 50 cases missed by standard tests.

Notably, fungi were found in one-third of patients, often undetected by routine methods, highlighting their overlooked role in HAP. The study also revealed high levels of multidrug resistance: 21% of bacterial genomes carried genes for resistance to at least three antibiotic classes, including in Staphylococcus epidermidis, usually seen as harmless but here acting as a reservoir for resistance.

Conclusion: Metagenomic sequencing provides a powerful tool to uncover the complex causes of HAP, detect hidden pathogens, and guide more effective treatment by identifying antimicrobial resistance.

Further reading: ResearchGate
Author(s): Cedric CS Tan et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!